HIGHLIGHTS
- who: Michiel Vlaming from the Division Laboratories, Pharmacy and Biomedical Genetics, deptof Genetics, University Medical Center Utrecht, Heidelberglaan, CX, Utrecht, The have published the research: Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study, in the Journal: (JOURNAL)
- what: The authors aim to implement so-called in the for patients with metastatic Discussion: This study is intended to be one of the largest studies on in The aim of the DISCOVER (Detecting Increased Susceptibility for Cancer in relatives by Offering genetic Variant Evaluation as Regular health . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.